Alloy Therapeutics Revenue
Biotechnology Research • 
Lexington, Massachusetts, United States • 101-200 Employees
Alloy Therapeutics revenue & valuation
| Annual revenue | $10,000,000 |
| Revenue per employee | $75,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $32,000,000 |
| Total funding | $42,000,000 |
Key Contacts at Alloy Therapeutics
Sharon Morgenbesser
Director, Alliance Management For Genetic Medicines
Jaime Lisk
Director, Hr Business Partner
Eugene Mironets
Associate Director Of Business Development
Laurel Handler-Vosen
Senior Director, Head Of People
Heather Cooke
Senior Director, Bispecific Antibody Engineering
Kelsey Cardenas
Director, Office Of The Ceo
Seung Joon Lee
Director
Davide Schiavone
Senior Director - Head Of Geo Core Genetically Engineered Organism
Melinda Smith
Associate Director Molecular Biology
Meghan Kelly
Senior Director
Company overview
| Headquarters | 44 Hartwell Ave, Boston, Massachusetts 02421, US |
| Phone number | +16172037111 |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Biotech, RNA, Drug Discovery, Immunotherapy, ASO, Monoclonal Antibodies, Bispecific Antibodies, TCR, Company Creation, Venture Studios, Chimeric Antigen Receptors, Biologics Discovery, Humanized Transgenic Mouse |
| Founded | 2017 |
| Employees | 101-200 |
| Socials |
Alloy Therapeutics Email Formats
Alloy Therapeutics uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@alloytx.com), used 52.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@alloytx.com | 52.9% |
{first initial}.{last name} | j.doe@alloytx.com | 44.8% |
{2char} | {2char}@alloytx.com | 2.3% |
About Alloy Therapeutics
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. From licensing our platforms, to working with us as a trusted discovery service partner, we have collaborated with over 170+ partners and counting including 18 of Fortune 50 Biopharmaceutical companies to enable the discovery of their next breakthrough biologic medicines. With Alloy, you can: • Access our ever-growing stable of antibody and bispecific discovery platforms that blend in vivo and in vitro wet-lab capabilities with AI/ML. Discover with us through our services or by licensing our technologies for use in your lab. • Unlock intracellular targets with the therapeutic potential of T cell receptor (TCR) modalities through our fully integrated Keyway™ TCRm discovery service offering. • Reach genetic disease targets at the nucleic acid level with our novel AntiClastic™ ASO Format, which enhances the molecule's potency while minimizing off-target interaction and inflammatory response. • Co-build new biotechnology companies that leverage our core platforms and service capabilities with Alloy's affiliated Venture Studio, 82VS. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Boston, MA, with labs in Cambridge, U.K.; Basel, CH; and Athens, GA. We reinvest 100% of our revenue back into innovation and access to innovation. Reach out, follow, and visit our website, to learn more about how we can make better medicines, together. https://www.alloytx.com/
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Alloy Therapeutics has 48 employees across 12 departments.
Departments
Number of employees
Alloy Therapeutics Tech Stack
Discover the technologies and tools that power Alloy Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
Security
Form builders
Analytics
Caching
JavaScript libraries
JavaScript libraries
WordPress themes
Page builders
Analytics
JavaScript libraries
Canada
Saudi Arabia
Frequently asked questions
4.8
40,000 users
